KRAS
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000568553.2
- Last updated: 2023-10-19
- Test version history
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Gastric cancer
Offered by Institute for Human Genetics
Overview
Test name
HelpThe name the laboratory assigns the test. Used as the default title of the page specific to the test.KRAS
This is a clinical test intended for HelpPurposes or indications for the test. Lab-provided.: Screening
Click Indication tab for more information.
informed consent and requisition form
Order URL HelpLink to the laboratory webpage with information about how to order this test. Please note that clicking on this link will open a new tab in your internet browser.: https://www.uniklinik-freiburg.de/humangenetik/formulare-infos.html
Methodology
HelpThe assay's major method category (biochemical, cytogenetic or molecular genetics); method category (i.e. enzyme assay, chromosome breakage studies, targeted mutation analysis); methodology (i.e. the name of the method used) and instruments used when performing this test.- Molecular Genetics
- CSequence analysis of the entire coding region
- Next-Generation (NGS)/Massively parallel sequencing (MPS)
Not provided
Clinical validity
HelpHow consistently and accurately the test detects or predicts the intermediate or final outcomes of interest. Lab-provided.Not provided
Test services
HelpLaboratory's order or catalog code for the test (used in the order requisition form).- Custom mutation-specific/Carrier testing, Order code: Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
- NCCN, 2023NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gastric Cancer, 2023
- NICE, 2023UK NICE Guideline (NG83), Oesophago-gastric cancer: assessment and management in adults, 2023
- OMIM
- View APC variations in ClinVar
- View CASP10 variations in ClinVar
- View KLF6 variations in ClinVar
- View ERBB2 variations in ClinVar
- View FGFR2 variations in ClinVar
- View IL1B variations in ClinVar
- View IL1RN variations in ClinVar
- View IRF1 variations in ClinVar
- View KRAS variations in ClinVar
- View MUTYH variations in ClinVar
- View PIK3CA variations in ClinVar
- RefSeqGene
- Coriell Institute for Medical Research
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.